Impax Settles With Daiichi, Genzyme Over Generic Welchol
Impax Laboratories Inc. said Thursday it had resolved patent litigation brought by Daiichi Sankyo Inc and Genzyme Corp. in Delaware over cholesterol drug Welchol, striking a deal that will allow Impax...To view the full article, register now.
Already a subscriber? Click here to view full article